Dr. Creagh Milford will continue to be interim president of retail health at CVS Health until the company finds a replacement ...

Mike Pykosz, the former CEO of Oak Street Health, will leave CVS Health as part of the company's latest leadership shake-up. As CMO, Chaguturu oversees CVS' medical affairs organization and is ...

Mike Pykosz, the co-founder of Oak Street Health and president ... and reshuffled its executive leadership. However, Pykosz was not forced out. According to CVS’ release, the executive informed ...

Mike Pykosz, the former CEO of Oak Street Health, will leave CVS Health as part of the company's latest leadership shake-up. CVS announced Tuesday that Sree Chaguturu, M.D., will step into the ...

The latest leadership change raises questions about the future of CVS’ healthcare delivery strategy, which includes primary care provider Oak Street Health and in-home care company Signify Health.

CVS subsidiary Oak Street Health has agreed to pay $60 million to settle accusations that it violated the False Claims Act by offering kickbacks to third-party insurance agents in return for ...

As other retailers exit or reconfigure the approach in primary care, CVS Health is choosing to double down. The company announced it plans to open 25 Oak Street Health clinics alongside their ...

CVS Health appears committed to growing its Oak Street Health business, but reportedly wants help with its expansion efforts. The retail giant is on the lookout for a private equity partner to ...

CVS Health Corp. (NYSE:CVS) is reportedly seeking a private equity partner to fund the expansion of Oak Street Health, the $10.6 billion primary care provider it acquired last year.

CVS Health is working with financial advisers to secure capital for new Oak Street clinics. Today's manic market swings are creating the perfect setup for Matt’s next volatility trade.

May 23 (Reuters) - CVS Health Corp (CVS.N), opens new tab has been seeking a private equity partner to fund growth at Oak Street Health, a primary care provider it bought a year ago, Bloomberg ...